Metabolic fate and cardiovascular effects of arsenic in rats and rabbits chronically exposed to trivalent and pentavalent arsenic.
Male rats and female rabbits exposed for eighteen and ten months, respectively, to 50 micrograms/ml of trivalent arsenic (As III) in drinking water showed reduction of stroke volume (SV) and cardiac output (CO) and increase of vascular resistance (VR), while no cardiovascular change was observed in male rats receiving 50 micrograms/ml of pentavalent arsenic (As V) for eighteen months. The exposed animals showed specific alterations in some neurohumoral and effector mechanisms regulating cardiovascular function (CF). Elevated levels of urinary As were found in all treated groups. However, there were significant differences in the urinary levels of dimethylarsenic acid (DMA), monomethylarsenic acid (MMA) and inorganic As, which depended on both animal species and the valency state of As. Thus, As(III) was methylated to a greater extent than As(V) in rats, with less elimination of inorganic As, while rabbits had a lower capacity to methylate As and to retain As in tissues than rats. Either cardiovascular effects or metabolism of As seemed to depend on its valency state and animal species.
D000818:Animals; D001149:Arsenates / Q000378:metabolism* / Q000494:pharmacology; D001151:Arsenic / Q000378:metabolism* / Q000494:pharmacology; D018053:Arsenites; D002339:Carotid Arteries / Q000502:physiology; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D008745:Methylation; D010275:Parasympathetic Nervous System / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D017670:Sodium Compounds; D013045:Species Specificity; D013564:Sympathetic Nervous System / Q000187:drug effects; D014628:Vagotomy
D001149:Arsenates; D018053:Arsenites; D017670:Sodium Compounds; C017947:sodium arsenite; C009277:sodium arsenate; D001151:Arsenic